Haniva was awarded a US Patent In March, 2017 for the Combination Therapy of non-thermal plasma and any DNA damaging agent activated by hypoxia (Patent number 9,586,056). As of May, 2021, they also received patent approval for their combination therapy from the Australian government.
Latigo Biotherapeutics
1 follower
Thermo Fisher Scientific
286 followers
Genentech
227 followers
Gilead Sciences
215 followers
Regeneron
184 followers
Biogen
167 followers
Vertex Pharmaceuticals
111 followers
Agilent Technologies
101 followers
Illumina
93 followers
Neuralink
91 followers
Alexion Pharmaceuticals
56 followers
Verily Life Sciences
49 followers